IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAD0. A total of 39 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $50,002 | -97.7% | 50,000 | -97.5% | 0.00% | -100.0% |
Q2 2019 | $2,142,000 | +116.4% | 2,006,000 | +123.1% | 0.02% | +100.0% |
Q1 2019 | $990,000 | +1767.9% | 899,000 | +1897.8% | 0.01% | – |
Q1 2018 | $53,000 | -97.9% | 45,000 | -97.9% | 0.00% | -100.0% |
Q4 2017 | $2,546,000 | +345.9% | 2,191,000 | +413.1% | 0.01% | +200.0% |
Q2 2017 | $571,000 | -8.1% | 427,000 | -20.9% | 0.00% | +33.3% |
Q4 2016 | $621,000 | -71.5% | 540,000 | -74.3% | 0.00% | -70.0% |
Q2 2016 | $2,182,000 | – | 2,099,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DeepCurrents Investment Group LLC | 15,056,000 | $16,316,000 | 0.43% |
CSS LLC/IL | 10,119,000 | $10,974,000 | 0.42% |
Context Capital Management, LLC | 2,500,000 | $2,706,000 | 0.37% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 10,000,000 | $10,835,000 | 0.30% |
WOLVERINE ASSET MANAGEMENT LLC | 33,392,000 | $36,208,000 | 0.27% |
HBK INVESTMENTS L P | 14,616,000 | $15,861,000 | 0.10% |
PALISADE CAPITAL MANAGEMENT, LP | 2,127,000 | $2,298,000 | 0.06% |
Verition Fund Management LLC | 4,453,000 | $4,819,000 | 0.04% |
LAZARD ASSET MANAGEMENT LLC | 15,000,000 | $16,233,000 | 0.02% |
Calamos Advisors LLC | 2,423,000 | $2,628,000 | 0.02% |